1-4 of 4
Oussama Abla
Close
Sort by
Journal Articles

Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease

Oussama Abla
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2023) 2023 (1): 386–395.
https://doi.org/10.1182/hematology.2023000439
Published: 2023
Journal Articles

Management of primary central nervous system lymphoma in children

Lisa Giulino-Roth, Oussama Abla, Tracy T. Batchelor
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 386–389.
https://doi.org/10.1182/asheducation-2016.1.386
Published: 2016
Journal Articles

Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition

Oussama Abla, Sheila Weitzman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 565–570.
https://doi.org/10.1182/asheducation.V2015.1.565.3919688
Published: 2015
Journal Articles

Uncommon histiocytic disorders: Rosai–Dorfman, juvenile xanthogranuloma, and Erdheim–Chester disease

Julien Haroche, Oussama Abla
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 571–578.
https://doi.org/10.1182/asheducation.V2015.1.571.3916289
Published: 2015